← Leaderboards
Maged M Henary
Massachusetts General Hospital
$3,266,074
Attributed
$7,231,097
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,231,097 · 3
By mechanism
R01$7,231,097 · 3
Top collaborators
- Hak Soo Choi8 shared
- Michael Bouvet3 shared
- Lacey R Mcnally3 shared
- Satoshi Kashiwagi1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Harald W. Jueppner$19,159,604
- Murat Bastepe$9,215,842
- Hak Soo Choi$7,452,919
- Thomas J Gardella$10,202,128
- Zdravka O. Medarova$10,579,501
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesToxic EffectDoseImageUptakeCellsPharmaceutical PreparationsTumorContrast MediaPerformanceDetectionMorbidity - Disease RateChemistryOperative Surgical ProceduresFluorescencePropertyEvaluationDrug KineticsImage-Guided Drug DeliveryQuantumImaging SystemIn VivoBiodistributionImage Guided
Grant awards (12)
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$699,269
R01 · FY2025 · CA
Development of an apoptosis biosensor for monitoring of breast cancer$533,998
R01 · FY2025 · EB
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$664,306
R01 · FY2024 · CA
Development of an apoptosis biosensor for monitoring of breast cancer$502,136
R01 · FY2024 · EB
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$733,271
R01 · FY2023 · CA
Development of an apoptosis biosensor for monitoring of breast cancer$495,147
R01 · FY2023 · EB
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.$658,475
R01 · FY2020 · EB
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor$651,080
R01 · FY2020 · EB
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.$658,475
R01 · FY2019 · EB
Image-Guided Drug Delivery for Alzheimer Disease$300,242
R01 · FY2019 · EB
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.$658,473
R01 · FY2018 · EB
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.$676,225
R01 · FY2017 · EB